Exploratory metabolomic analysis for identifying systemic signatures of Helicobacter pylori infection in children - Poll - MDSpire

Exploratory metabolomic analysis for identifying systemic signatures of Helicobacter pylori infection in children

  • By

  • Weronika Gonciarz

  • Lucyna Kozlowska

  • Marta Stelmasiak

  • Magdalena Wozniczka

  • Magdalena Chmiela

  • June 16, 2026

  • 0 min

Share

Original Source(s)

Exploratory metabolomic analysis for identifying systemic signatures of Helicobacter pylori infection in children

  • by Weronika Gonciarz, Lucyna Kozlowska, Marta Stelmasiak, Magdalena Wozniczka, Magdalena Chmiela

  • June 16, 2026

Related Content

This Week’s Biopharma News: KRAS Breakthrough and ADC Momentum

Revolution’s KRAS breakthrough, strong ADC signals from GSK, and shifting regulatory and dealmaking dynamics define this week in biopharma

  • April 21, 2026

  • 4 min
Advances in Hodgkin Lymphoma Treatment: Clinical Considerations for Managing Toxicities in Nivolumab-AVD Therapy

One of the most promising developments in advanced-stage Hodgkin lymphoma is the nivolumab-AVD regimen, which combines nivolumab with doxorubicin, vinblastine, and dacarbazine. This article provides practical knowledge for advanced practitioners to effectively manage the most common toxicities associated with nivolumab-AVD.

Distress Screening in a Cancer Survivorship Clinic: Impact on Psychosocial Referrals

This quality improvement project found that using a distress screening tool for head and neck cancer patients who were 2 or more years post-treatment led to an increased number of referrals for psychosocial needs.